Veterinary Medicines

Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats

Authorised
  • Lidocaine hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats
LIDCOSAL 16,2 MG/ML SOLUTION POUR PULVERISATION LARYNGOPHARYNGEE POUR CHATS
Active substance:
  • Lidocaine hydrochloride monohydrate
Target species:
  • Cat
Route of administration:
  • Laryngopharyngeal use

Product details

Active substance and strength:
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Laryngopharyngeal spray, solution
Withdrawal period by route of administration:
  • Laryngopharyngeal use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR02AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • A clear, colourless Type I glass vial with a polypropylene and polyethylene spray pump and actuator containing 10 ml. Vial packaged in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4233977 1/2018
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0554/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 10/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."